StockData
Evaxion A/S logo

Evaxion A/S (EVAX) stock

EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$2.78+0.01 (+0.36%)

Close on Nov 17, 2026Market cap $23.19MP/E –Yield –

Evaxion A/S total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Evaxion A/S's total debt was $5.31M at Jun 30, 2026. For fiscal 2025 it was $5.54M, down 32.2% from the year before. The highest annual figure on record is $8.65M in fiscal 2023.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.54M-32.2%
FY2024Dec 31, 2024$8.17M-5.6%
FY2023Dec 31, 2023$8.65M+8.1%
FY2022Dec 31, 2022$8.00M+583.8%
FY2021Dec 31, 2021$1.17M-86.3%
FY2018Dec 31, 2018$8.57M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$5.31M-36.9%
Q4 FY2025Dec 31, 2025$5.54M-36.0%
Q2 FY2025Jun 30, 2025$9.22M+12.0%
Q4 FY2024Dec 31, 2024$8.17M+2.1%
Q2 FY2024Jun 30, 2024$8.42M+12.9%
Q4 FY2023Dec 31, 2023$8.65M+10.2%
Q2 FY2023Jun 30, 2023$8.23M+603.2%
Q4 FY2022Dec 31, 2022$8.00M+535.4%
Q2 FY2022Jun 30, 2022$7.46M-13.0%
Q1 FY2022Mar 31, 2022$7.84M–
Q4 FY2021Dec 31, 2021$1.17M–
Q3 FY2021Sep 30, 2021$1.26M–
Q4 FY2018Dec 31, 2018$8.57M–

More Evaxion A/S figures

See a number that looks wrong?